Skip to main content
Clinical Trials/NL-OMON47499
NL-OMON47499
Completed
Phase 3

*Effectiveness of Ultrasound Guided Percutaneous treatment of Lateral Epicondylitis using standardized perforation with application of autologous blood, dextrose or perforation only, in relation to pain and functional recovery; A randomized controlled trial * - Ultrasound guided needle therapy in LE

Amphia Ziekenhuis0 sites165 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
lateral epicondylitis
Sponsor
Amphia Ziekenhuis
Enrollment
165
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Amphia Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • Patients referred by their GP to the orthopaedic surgeon diagnosed with unilateral Lateral Epicondylitis
  • Age between 18 and 70 years
  • Unsuccessful conservative treatment
  • Able to read and write in Dutch
  • Provision of informed consent by patient.

Exclusion Criteria

  • Prior injection therapy (during this episode of LE), surgery or trauma at the affected elbow
  • Inflammatory diseases (i.e. rheumatoid arthritis, psoriatic arthritis, or reactive arthritis)
  • Patients with any other elbow pathology
  • Neck pain or shoulder pain correlated with elbow pain such as C6 radiculopathy or with disability of the arm or other chronic widespread pain syndromes
  • Traumatic onset of LE.
  • Bilateral LE (mild cases of LE on the contralateral elbow without functional limitations are allowed).
  • Abnormalities on the X\-ray.
  • Patients with additional pain at the medial epicondyl.
  • Allergy for lidocaine

Outcomes

Primary Outcomes

Not specified

Similar Trials